Genor Biopharma targets $371m from Hong Kong IPO
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
Asia

Genor Biopharma targets $371m from Hong Kong IPO

Jonathan Breen
September 23, 2020 06:45 AM
Pharma_drugs_adobe_575x375.jpg

JHBP (CY) Holdings, a holding company for China’s Genor Biopharma, hit the road for its Hong Kong IPO on Wednesday. It is aiming to raise up to HK$2.9bn ($371.2m).

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Macquarie GroupJP MorganEquity IPOsHealth and BiotechEquityChina Merchants Bank CoChinaJefferies LLCHong Kong SARAsiaGreater ChinaHaitong SecuritiesNortheast AsiaAsia PacificEmerging MarketsSRIGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article